NanoString Technologies Inc NSTG:NASDAQ

Last Price$31.53NASDAQ Previous Close - Last Trade as of 3:59PM ET 6/04/20

Today's Change+0.42(1.35%)
Bid (Size)$28.80 (1)
Ask (Size)$34.19 (1)
Day Low / High$30.20 - 32.00
Volume722.7 K
 

View Biotechnology IndustryPeer Comparison as of 06/04/2020

 

NanoString Technologies Inc ( NASDAQ )

Price: $31.53
Change: +0.42 (1.35%)
Volume: 722.7 K
3:59PM ET 6/04/2020
 
 

Esperion Therapeutics Inc ( NASDAQ )

Price: $43.45
Change: +1.25 (2.96%)
Volume: 736.2 K
4:00PM ET 6/04/2020
 
 

Myriad Genetics Inc ( NASDAQ )

Price: $15.92
Change: +0.42 (2.71%)
Volume: 1.9 M
3:59PM ET 6/04/2020
 
 

Intellia Therapeutics Inc ( NASDAQ )

Price: $20.64
Change: -1.69 (7.57%)
Volume: 2.1 M
4:00PM ET 6/04/2020
 
 

Cytokinetics Inc ( NASDAQ )

Price: $20.04
Change: -0.56 (2.72%)
Volume: 430.4 K
4:00PM ET 6/04/2020
 

Read more news Recent News

--Analyst Actions: UBS Cuts NanoString Technologies Price Target to $38 From $40, Maintains Buy Rating
1:34PM ET 4/28/2020 MT Newswires

Price: 30.07, Change: -1.16, Percent Change: -3.71 ...

NanoString Technologies Preliminary Q1 Revenue Up 15% from Year Ago, Pulls 2020 Guidance
4:19PM ET 4/06/2020 MT Newswires

NanoString Technologies (NSTG) on Monday reported product and service revenue of about $24.5 million in Q1, up 15% from a year ago and against its own...

Insider Trends: NanoString Technologies Insider Exercises Option/Derivative Security to Acquire Stock Sells Portion to Pay Tax, Buy Trend Intact
5:24PM ET 3/18/2020 MT Newswires

R Bradley Gray, Director and President & CEO, exercised options/derivative securities for 21,994 shares of NanoString Technologies (NSTG) and sold 8,655...

Insider Trends: NanoString Technologies Insider Exercises Option/Derivative Security to Acquire Stock Sells Portion to Pay Tax, Buy Trend Intact
4:18PM ET 3/13/2020 MT Newswires

On Mar 11, 2020, Joseph M Beechem, SVP, Research & Development, exercised options/derivative securities for 18,431 shares of NanoString Technologies (NSTG)...

Company Profile

Business DescriptionNanoString Technologies, Inc. engages in the development and commercialization of instrument and services for profiling of genes and proteins from tissue sample. It offers GeoMx Digital Spatial Profiler, nCounter Systems, analysis solutions, gene expression panels, Vantage 3D Assays, miRNA Assays, custom solutions, and Sample Prep and nCounter Consumables. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA. View company web site for more details
Address530 Fairview Avenue North
Seattle, Washington 98109
Phone+1.888.358.6266
Number of Employees476
Recent SEC Filing06/03/20204

Company Highlights

Price Open$30.69
Previous Close$31.11
52 Week Range$13.85 - 36.43
Market Capitalization$1.2 B
Shares Outstanding37.7 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement07/29/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.51
Beta vs. S&P 500N/A
Revenue$106.7 M
Net Profit Margin-46.13%
Return on Equity-57.73%

Analyst Ratings as of 11/12/2019

Buy
3
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset